Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01576510 · ClinicalTrials.gov registry record · NA

fMRI Predictors of Treatment Response in Posttraumatic Stress Disorder (PTSD)

A NA study of Posttraumatic Stress Disorder (PTSD), sponsored by Research Foundation for Mental Hygiene.

Completed
Registry status
NA
Development phase
95
Enrollment target
1
Study location

NCT01576510 is a NA study of Posttraumatic Stress Disorder (PTSD) that has completed, run by Research Foundation for Mental Hygiene. The registered enrollment target is 95 participants, below the 110-participant average among 17 other Posttraumatic Stress Disorder (PTSD) trials with a reported enrollment target (14% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01576510, a NA study of Posttraumatic Stress Disorder (PTSD), has completed, sponsored by Research Foundation for Mental Hygiene.

COMPLETED
Registry status
NA
Development phase
95 participants
Enrollment target
1
Study location

Study Summary

To employ a fear learning-extinction paradigm with functional magnetic resonance imaging (fMRI) and skin conductance response (SCR) assessments among patients with posttraumatic stress disorder (PTSD) and trauma exposed healthy controls, aiming to a) clarify neural circuits underlying PTSD and b) to probe brain based predictors of symptomatic improvement in response to Prolonged Exposure (PE) treatment, and first line treatment for PTSD.

Interventions

  • BEHAVIORAL Prolonged Exposure (PE)

Study Locations (1)

New York

  • New York State Psychiatric Institute - New York

Trial Details

FieldValue
Enrollment Target 95 participants
Start Date 2010-08
Est. Completion 2014-06
Phase NA

What the Registry Record Tells You About NCT01576510

The ClinicalTrials.gov registry entry for NCT01576510 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 95 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 110-participant average among 17 other Posttraumatic Stress Disorder (PTSD) trials with a reported enrollment target (14% lower). The listed sponsor is Research Foundation for Mental Hygiene, which has 27 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Posttraumatic Stress Disorder (PTSD) appearing as the primary indexed condition, and to 1 intervention - of which Prolonged Exposure (PE) is the first listed.

NCT01576510 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT01576510 about?

NCT01576510 is a clinical study titled "fMRI Predictors of Treatment Response in Posttraumatic Stress Disorder (PTSD)". To employ a fear learning-extinction paradigm with functional magnetic resonance imaging (fMRI) and skin conductance response (SCR) assessments among patients with posttraumatic stress disorder (PTSD) and trauma exposed healthy controls, aiming to a) clarify neural circuits underlying PTSD and b) to...

What is the current status of trial NCT01576510?

This trial is currently completed. It is a NA study. The enrollment target is 95 participants. The study started on 2010-08. Estimated completion is 2014-06.

What conditions does trial NCT01576510 study?

This clinical trial studies the following conditions: Posttraumatic Stress Disorder (PTSD).

What interventions are being tested in trial NCT01576510?

The interventions under investigation include: Prolonged Exposure (PE) (BEHAVIORAL).

Who is sponsoring clinical trial NCT01576510?

This trial is sponsored by Research Foundation for Mental Hygiene, which has 27 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01576510 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Posttraumatic Stress Disorder (PTSD)

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.